Market Context — Why This Technology, Why Now

The global biotechnology and pharmaceutical sectors are experiencing unprecedented demand for high-precision, reproducible cell culture and observation techniques. This is driven by advancements in personalized medicine, the acceleration of drug discovery pipelines, and stringent regulatory requirements for biopharmaceutical manufacturing. Technologies that standardize processes, reduce human error, and enhance data integrity, like this cell observation system, are critical for maintaining competitive advantage and ensuring compliance in a rapidly evolving market landscape.

Key Competitive Advantages
01

Halves Observation Time by ~50% with consistent field identification, regardless of operator experience

02

Standardizes Cell Quality Control by reducing observer variability and enabling highly reproducible data acquisition

03

Ensures Low-Cost Integration into existing manufacturing processes without requiring special modifications to current microscope systems

Market Opportunity
Regenerative Medicine & Cell Therapy
$3.0B–$3.5B globally (AI est.)
The advancement of personalized medicine and the rapid development of new therapies are driving a surge in demand for high-quality cell culture and observation technologies.
Regenerative medicine therapy developers Cell therapy manufacturing organizations Biotech research institutions
Drug Discovery & Screening
$2.0B–$2.5B globally (AI est.)
Highly reproducible cell observation is essential for efficient compound screening and the development of disease models, forming a critical foundation for drug discovery.
Pharmaceutical R&D departments Contract research organizations (CROs) Academic drug discovery labs
Biopharmaceutical Manufacturing
$1.5B–$2.0B globally (AI est.)
Strict quality control and efficiency are paramount in biopharmaceutical manufacturing processes. Standardized cell observation directly contributes to increased productivity.
Biopharmaceutical manufacturers Quality control solution providers Bio-reactor and cell culture equipment suppliers
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent provides robust protection for a cell observation container and cell transport device, specifically covering the configuration of reference lines and indicators formed as recesses on the container's bottom wall. The broad scope, encompassing 12 claims from structural components to manufacturing methods, was secured after successfully overcoming examiner rejections, demonstrating clear differentiation from prior art.

Competitive White Space

While the patent covers the container and transport device, adjacent white space exists in advanced automated microscopy systems, AI-driven image analysis software for cell behavior, and novel bioreactor designs that integrate such observation capabilities.

Economic Impact
~$100K/year estimated research cost reduction per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Assuming an annual personnel cost of ~$53.5K/researcher (AI est.) and 1,000 hours/year spent on observation tasks. A 30% reduction in observation time for 5 researchers could yield a direct cost saving of ~$80K/year (AI est.). Additional benefits from quality improvement, reduced re-experimentation, and accelerated product development could lead to a total economic impact of over ~$100K/year (AI est.).

Speed to Market
5× faster than in-house development
This technology involves forming reference lines and indicators as recesses on the bottom wall of a container, a manufacturing process presumed to be established. As the patent has been granted, concept validation and basic research phases are complete, significantly shortening the timeline compared to new development. Its high compatibility with existing cell culture and observation systems suggests rapid market entry.
Competitive Positioning

X: Observation Efficiency and Reproducibility
Y: Ease of Adoption and Versatility

Business Models & Applications
🔬 Technology Licensing
License this patented technology to culture container manufacturers. This enables them to add differentiated, high-value features to existing product lines.
🧪 Joint Development & OEM
Collaborate with pharmaceutical and biotech companies to co-develop custom containers optimized for specific cell culture applications, meeting high-precision observation needs.
💡 Research Platform Solutions
Establish a comprehensive research support platform, combining observation containers with AI-powered cell image analysis and automated culture systems.
Adjacent Application Opportunities
🏥 Diagnosis & Testing
Enhance Pathological Diagnosis Accuracy
Enable highly reproducible tracking of specific regions in tissue culture or biopsy cell observation, reducing diagnostic variability. Potential integration with AI-driven image diagnostics could enhance efficiency and accuracy in clinical pathology, impacting millions of diagnostic tests annually.
🌱 Plant Biotechnology
Streamline Plant Cell Culture
Efficiently track the growth of specific cell populations in rare plant tissue culture or genetically modified plant cell line selection processes. This could contribute to streamlining new variety development and useful substance production in agriculture, potentially accelerating agricultural R&D cycles by 15-20%.
Integration Roadmap — Estimated 12-Month Deployment
Technology Evaluation & Design
Duration: 3 months
Evaluate compatibility with the licensee's existing observation systems and culture protocols, then develop the initial design for containers incorporating this technology. Define specific observation needs and requirements.
Prototyping & Validation
Duration: 6 months
Manufacture prototype containers based on the design and conduct performance validation in the licensee's lab environment. Assess reproducibility of identical fields, impact on cells, and durability, optimizing the design as needed.
Full-Scale Implementation & Deployment
Duration: 3 months
Based on validation results, formulate a plan for full-scale introduction into container manufacturing lines and establish mass production capabilities. Begin internal deployment and external product offerings to secure market advantage.
Technical Feasibility
This technology, which involves forming reference lines and indicators as recesses on the bottom wall of a cell observation container, can likely be integrated relatively easily into existing culture container manufacturing processes. It does not require special electronic components or complex software and exhibits high compatibility with general-purpose microscope systems, indicating high technical feasibility for introduction without significant capital investment.
Success Scenario
Upon adopting this technology, researchers could potentially reduce the time required for cell observation by an average of 30%. This could enable more experiments to be conducted in parallel, estimated to shorten the lead time for new drug development and regenerative medicine research by up to 20%. Consequently, the time to market could be significantly accelerated.
Patent Record
APPLICATION NO.
特願2022-573432
REGISTRATION NO.
7251867
FILING DATE
2022/07/05
GRANT DATE
2023/03/27
EXPIRATION DATE
2042/07/05
PATENT HOLDER
国立研究開発法人農業・食品産業技術総合研究機構
Examination History
2022年11月29日
出願審査請求書
2022年11月29日
手続補正書（自発・内容）
2022年11月29日
早期審査に関する事情説明書
2022年12月23日
早期審査に関する通知書
2022年12月23日
拒絶理由通知書
2023年02月01日
意見書
2023年02月01日
手続補正書（自発・内容）
2023年03月07日
特許査定